does medi-cal cover semaglutide for weight loss GLP-1 Medication Coverage Changes in 2026 Semaglutide GLP-1 for Medical Weight

Different vial, different number on the syringe, same amount of drug entering your body

It feels excessive at first but becomes automatic within a week

This reduction in type 2 diabetes lowers the risk of heart disease or other cardiometabolic complications

For instance, in October 2024, Novo Nordisk made significant strides with Rybelsus, as the company announced its plan to expand the drugs indication to prevent major adverse cardiovascular events (MACE) in patients with Type 2 diabetes, cardiovascular disease (CVD), or chronic kidney disease (CKD)

By dramatically improving these metabolic markers, GLP-1 agonists indirectly attack aging at its root